bronchiolitis


Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.

bronchiolitis

(ˌbroŋkiəʊˈlaɪtɪs)
n
(Medicine) a condition in which the small airways in the lungs become inflamed by a virus. It is most common in infants, who become breathless in severe cases. Recurrent attacks may lead to asthma
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.bronchiolitis - inflammation of the membranes lining the bronchioles
bronchitis - inflammation of the membranes lining the bronchial tubes
Translations

bron·chi·ol·i·tis

n. bronquiolitis, infl. de los bronquiolos.

bronchiolitis

n bronquiolitis f; — obliterans bronquiolitis obliterante
References in periodicals archive ?
Our programs in Bronchiolitis and NTM will both move forward in 2020 with data from two separate studies with the pivotal study for bronchiolitis anticipated to be completed in 2021 ." Mr.
M2 EQUITYBITES-March 26, 2019-Breath Therapeutics begins global Phase 3 trials of La[euro]'CsAa[euro]'i for treating Bronchiolitis Obliterans Syndrome
It is the most common etiologic pathogen; however, other viral pathogens such as adenovirus, coronavirus, parainfluenza, influenza, rhinovirus, human metapneumovirus, human bocavirus, and human coronaviruses cause acute bronchiolitis (3,4).
AS WELL as being the peak season for coughs and colds, this time of year is when babies and young children often succumb to the common - but potentially more serious - lung infection bronchiolitis.
PREMATURITY RISK BABIES are at greater risk of 8 developing severe bronchiolitis if they were born prematurely (at less than 37 weeks), are under 12 weeks old or were born with a heart or lung condition.
4 RAPID BREATHING IN SOME cases, bronchiolitis can become severe and cause children to struggle to breathe - their breathing rate can increase to 50-60 breaths a minute or they may develop a temperature of 38degC (100.4degF) or higher.
However it can lead to bronchiolitis in babies and younger children which may require medical attention.
17, 2018 (HealthDay News) -- Variables have been identified that predict escalated care for infants with bronchiolitis, according to a study published in the September issue of Pediatrics.
It was reported yesterday that the US Food and Drug Administration (USFDA) has granted orphan drug designation to United States-based Onspira Therapeutics for its investigational product, OSP-101, intended for treating Bronchiolitis Obliterans.
Objective: To compare the use of 3.0% hypertonic saline versus 0.9% normal saline for nebulization in children who presented with acute bronchiolitis.

Full browser ?